Cargando…
Good ACE, bad ACE do battle in lung injury, SARS
Two studies show how the enzyme ACE2 protects against lung injury caused by SARS and other agents. ACE2 seems to counteract the effects of ACE, which are more damaging (pages 875–879).
Autores principales: | Nicholls, John, Peiris, Malik |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group US
2005
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095949/ https://www.ncbi.nlm.nih.gov/pubmed/16079870 http://dx.doi.org/10.1038/nm0805-821 |
Ejemplares similares
-
ACE2 and Diabetes: ACE of ACEs?
por: Batlle, Daniel, et al.
Publicado: (2010) -
Exploring the Mystery of Angiotensin-Converting Enzyme II (ACE2) in the Battle against SARS-CoV-2
por: Sharma, Divakar, et al.
Publicado: (2021) -
Sex differences in the lung ACE/ACE2 balance in hypertensive rats
por: Martins, Flavia L., et al.
Publicado: (2021) -
Role of ACE, ACE2 and Neprilysin in the Kidney
por: Chappell, Mark C.
Publicado: (2007) -
ACE1 polymorphism and progression of SARS
por: Itoyama, Satoru, et al.
Publicado: (2004)